Telemark Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Telemark Asset Management's MRNA Position: Q3 2026 in Review
Telemark Asset Management reduced its Moderna (MRNA) stake by 29% in Q3 2026, selling an estimated $21.6M and leaving 500,000 shares worth $96.3M. The position accounts for 6.91% of the portfolio, ranked #2.
Telemark Asset Management first reported a position in MRNA in Q1 2021 and has held it in 17 quarters since. The position peaked at $135M in Q3 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Telemark Asset Management held 500,000 shares of Moderna worth $96.3M as of Q3 2026.
- Telemark Asset Management sold 200,000 Moderna shares in Q3 2026, an estimated $21.6M.
- Moderna made up 6.91% of Telemark Asset Management's portfolio in Q3 2026, its #2 holding.
- Telemark Asset Management first reported a position in Moderna in Q1 2021 and has held it in 17 quarters since.
- Telemark Asset Management's Moderna position peaked at $135M in Q3 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Telemark Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.